Which super funds hold Paradigm Biopharmaceuticals Ltd?

As at 31 December 2025, 3 Australian super investment options in our dataset held Paradigm Biopharmaceuticals Ltd, the largest weighting being 0.10% in Direct Investment Option (Accumulation) (CareSuper).

Options holding it

3

Largest weighting

0.10%

Direct Investment Option (Accumulation) · CareSuper

Funds & options holding Paradigm Biopharmaceuticals Ltd

Australian super investment options disclosing a holding in Paradigm Biopharmaceuticals Ltd. Figures aggregate each option's disclosed line items for this security, as at each option's own reporting date.

FundPhaseOptionWeightingValue (AUD)As at
CareSuperAccumulationDirect Investment Option (Accumulation)
0.10%
$237,00831 December 2025
AustralianSuperAccumulationMember Direct (Accumulation)
0.00%
$191,31631 December 2025
AustralianSuperRetirementMember Direct (Income)
0.01%
$66,29131 December 2025

This page surfaces figures disclosed by the funds themselves under Portfolio Holdings Disclosure (Schedule 8D), each as at the date shown. It is factual disclosure information, not financial advice or a recommendation.

Methodology — how holdings are sourced, resolved and aggregated.

LookThrough shows the actual holdings inside Australian super funds, with cross-fund look-through.

  • 4 of 86 funds
  • 36 of 111 options reviewed
  • 7,010 of 7,168 securities reviewed

© 2026 LookThrough. Factual disclosure information — not financial advice, a rating or a recommendation.